natgillin/translations-raw huggingface dataset:
• Inflammation of sinuses (sinusitis, a feeling of tension or fullness in the nose, cheeks and behind the eyes, sometimes with a throbbing ache). 
• vnetje sinusov (sinusitis, občutek napetosti ali polnosti nosu, lic in predela za očmi, včasih z utripajočo bolečino);
Children may also experience anxiety, sleep disorders and behavioural changes, including hyperactivity and irritability. 
Pri otrocih se lahko pojavijo tudi tesnobnost, motnje spanja in vedenjske spremembe, vključno s hiperaktivnostjo in razdražljivostjo.
Two children on salmeterol/fluticasone propionate and 5 children on fluticasone propionate withdrew because of worsening asthma. 
Dva otroka na salmeterolu/flutikazonpropionatu in 5 otrok na flutikazonproprionatu je zaradi poslabšanja astme izstopilo iz študije.
• Fluticasone propionate is a corticosteroid which reduces swelling and irritation in the lungs. 
• Flutikazonpropionat je kortikosteroid, ki zmanjšuje otekanje in draženje v pljučih.
You may be very wheezy and cough or be short of breath. 
Morda boste zelo piskajoče dihali, kašljali ali ostali brez sape.
• Very fast heart beat (tachycardia). 
• zelo hitro utripanje srca (tahikardija);
If necessary you may wipe the mouthpiece of your inhaler after use with a dry cloth or tissue. 
Po potrebi lahko ustnik inhalatorja po uporabi obrišete s suho krpo ali robčkom.
These are often used to treat asthma. 
Ta se pogosto uporabljajo za zdravljenje
It is impossible to accidentally take extra medicine or a double dose in 
Nemogoče je, da bi po nesreči uporabili več zdravila ali dvojni odmerek v eni inhalaciji.
All subjects with asthma or COPD achieved PIFR values greater than 60L/min after optimal training. 
Vse osebe z astmo ali KOPB so dosegle vrednosti PIFR nad 60 l/min po optimalni vadbi.
Administration of Aerivio Spiromax to pregnant women should only be considered if the expected benefit to the mother is greater than any possible risk to the fetus. 
Zato naj se zdravilo Aerivio Spiromax pri nosečnicah uporablja samo, če so pričakovane koristi za mater večje od vseh možnih tveganj za plod.
In a small study in healthy volunteers, the slightly less potent CYP3A inhibitor ketoconazole increased the exposure of fluticasone propionate after a single inhalation by 150%. 
V majhni študiji pri zdravih prostovoljcih je nekoliko manj močan zaviralec CYP3A ketokonazol zvišal izpostavljenost flutikazonpropionatu po enkratni inhalaciji za 150 %.
It is important to inhale forcefully to ensure optimal dosing. 
Za zagotovitev optimalnega odmerjanja je pomembno silovito vdihniti.
Oral corticosteroids and antibiotics were allowed for the acute treatment of COPD exacerbations with specific guidelines for use. 
Peroralni kortikosteroidi in antibiotiki so bili dovoljeni za akutno zdravljenje poslabšanj KOPB s posebnimi navodili za uporabo.
• The mouthpiece will still ‘click' even when your inhaler is empty. 
• Ustnik še naprej klika, tudi ko je inhalator prazen.
Each dose contains approximately 10 milligrams of lactose (as monohydrate). 
En odmerek vsebuje približno 10 miligramov laktoze (v obliki monohidrata).
Do not try to take your inhaler apart, remove or twist the mouthpiece cover. 
Ne poskušajte razstaviti inhalatorja oziroma odstraniti ali zasukati pokrovčka ustnika.
• Use your Aerivio Spiromax every day until your doctor advises you to stop. 
• Zdravilo Aerivio Spiromax uporabljajte vsak dan, dokler vam zdravnik ne svetuje, da nehate.
You may also notice itching, a rash (hives) and swelling (usually of the face, lips, tongue or throat), or you may suddenly feel that your heart is beating very fast or you feel faint and light headed (which may lead to collapse or loss of consciousness). 
Opazite lahko tudi srbenje, izpuščaj (koprivnico) in oteklost (običajno obraza, ustnic, jezika ali žrela) ali pa nenadoma čutite zelo hitro utripanje srca, omedlevico ali omotico (kar lahko vodi v kolaps ali izgubo zavesti).
In TORCH, older patients, patients with a lower body mass index (<25 kg/m2) and patients with very severe disease (FEV1<30% predicted) were at greatest risk of developing pneumonia regardless of treatment. 
V študiji TORCH so pri starejših bolnikih, bolnikih z nižjim indeksom telesne mase (< 25 kg/m2) in bolnikih z zelo hudo obliko bolezni (pričakovan FEV1 < 30 %) opazili največje tveganje za pojav pljučnice ne glede na zdravljenje.
Aerivio Spiromax is not available on the market at strengths lower than 50/500 microgram. 
Zdravilo Aerivio Spiromax na trgu ni na voljo v jakosti, manjši od 50/500 mikrogramov.
Co-administration with erythromycin was not associated with any serious adverse effects. 
Sočasna uporaba eritromicina ni bila povezana z nobenimi resnimi neželenimi učinki.
If you get any of these effects or if they happen suddenly after using Aerivio Spiromax, stop using Aerivio Spiromax and tell your doctor straight away. 
Če se pojavi kateri koli od teh neželenih učinkov ali če se ti pojavijo nenadoma po uporabi zdravila Aerivio Spiromax, takoj prenehajte uporabljati zdravilo Aerivio Spiromax in to takoj povejte zdravniku.
• Uneven or irregular heart beat or an extra heart beat (arrhythmias). 
• neenakomerno ali nepravilno bitje srca ali dodatni srčni utrip (aritmije).
If you are using Aerivio Spiromax for asthma, your doctor will want to check your symptoms regularly. 
Če uporabljate zdravilo Aerivio Spiromax za astmo, bo zdravnik redno spremljal vaše simptome.
The benefits of inhaled fluticasone propionate therapy should minimise the need for oral steroids, but patients transferring from oral steroids may remain at risk of impaired adrenal reserve for a considerable time. 
Koristni učinki vdihanega flutikazonpropionata bi morali minimizirati potrebo po peroralnih steroidih, toda bolnike, ki preidejo s peroralnih steroidov, lahko še dolgo ogroža zmanjšanje adrenalne rezerve.
• Medicines to treat infections (such as ritonavir, ketoconazole, itraconazole and erythromycin). 
• Zdravila za zdravljenje okužb (kot so ritonavir, ketokonazol, itrakonazol in eritromicin).
Your doctor will help you to manage your asthma and will adjust the dose of this medicine to the lowest dose that controls your asthma. 
Zdravnik vam bo pomagal pri obvladovanju astme in prilagodil odmerek tega zdravila na najmanjši odmerek, ki nadzoruje vašo astmo.
Your doctor, nurse or pharmacist should provide you with training on how to use your inhaler, including how to take a dose effectively. 
Zdravnik, medicinska sestra ali farmacevt vas morajo naučiti pravilne uporabe inhalatorja, vključno z učinkovitim jemanjem odmerka.
In a 12-week trial of children 4 to 11 years of age [n=203] randomized in a parallel-group study with persistent asthma and who were symptomatic on inhaled corticosteroid, safety was the primary objective. 
V 12-tedenskem preskušanju pri otrocih s persistentno astmo, starih od 4 do 11 let [n = 203], ki so imeli simptome ob uporabi inhalacijskih kortikosteroidov in so bili randomizirani v študijo s paralelnimi skupinami, je bila varnost glavni cilj preskušanja.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. 
Če ste noseči, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom ali farmacevtom, preden vzamete to zdravilo.
The disposition of fluticasone propionate is characterised by high plasma clearance (1150 mL/min), a large volume of distribution at steady-state (approximately 300 L) and a terminal half-life of approximately 8 hours. 
Za razporeditev flutikazonpropionata so značilni velik očistek iz plazme (1.150 ml/min), velik volumen porazdelitve v stanju dinamičnega ravnovesja (približno 300 l) in približno 8-urni končni razpolovni čas.
Read the package leaflet carefully before use. 
Pred uporabo preberite priloženo navodilo!
Then breathe out gently (do not breathe out through the inhaler). 
Nato nežno izdihnite (ne izdihnite skozi inhalator).
This will make sure that it works properly in controlling your asthma or COPD. 
To zagotavlja njegovo ustrezno učinkovanje in nadzor vaše astme ali KOPB.
Combined asthma-related death or life-threatening experience 
Kombinacija z astmo povezanih smrtnih izidov ali življenje ogrožajočih dogodkov
In addition there are only limited data available on the pharmacokinetics of salmeterol because of the technical difficulty of assaying the drug in plasma due to the low plasma concentrations at therapeutic doses (approximately 200 picogram/mL or less) achieved after inhaled dosing. 
Podatki o farmakokinetiki salmeterola so poleg tega omejeni zaradi tehnične težavnosti določanja koncentracije v plazmi, ki je po vdihavanju terapevtskih odmerkov nizka (približno 200 pikogramov/ml ali manj).
• Chronic obstructive pulmonary disease (COPD), to reduce the number of flare ups of symptoms. 
• kronične obstruktivne pljučne bolezni (KOPB), za zmanjšanje števila izbruhov simptomov.
Systemic effects may occur, particularly at high doses prescribed for long periods. 
Lahko se pojavijo sistemski učinki, zlasti pri zdravljenju z velikimi odmerki, predpisanimi za daljše obdobje.
Allergic reactions: you may notice your breathing suddenly gets worse immediately after using Aerivio Spiromax. 
Alergijske reakcije: opazite lahko, da se dihanje poslabša takoj po uporabo zdravila Aerivio Spiromax.
Breathe in forcefully and deeply through the mouthpiece. 
Skozi ustnik silovito in globoko vdihnite.
Acute: Acute inhalation of fluticasone propionate doses in excess of those recommended may lead to temporary suppression of adrenal function. 
Akutno: Akutno vdihavanje flutikazonpropionata v odmerkih, ki presegajo priporočene, lahko povzroči prehodno zavrtje delovanja nadledvičnih žlez.
If you open and close the mouthpiece without taking an inhalation the dose will be securely held inside the inhaler ready for the next inhalation. 
Če ustnik odprete in zaprete, odmerka pa ne inhalirate, ostane odmerek varno shranjen znotraj inhalatorja in pripravljen za naslednjo inhalacijo.
Patients should be given a strength of salmeterol/fluticasone propionate inhaler containing the appropriate fluticasone propionate dosage for the severity of their disease. 
Bolnikom je treba dati jakost inhalatorja s salmeterolom/flutikazonpropionatom, ki vsebuje ustrezen odmerek flutikazonpropionata glede na resnost njihove bolezni.
The use of concurrent inhaled long-acting β2 agonists and anticholinergic drugs, salbutamol/ipratropium bromide combination products, oral β2 agonists and theophylline preparations were not allowed during the treatment period. 
Sočasna uporaba inhaliranih dolgodelujočih agonistov β2 in antiholinergičnih zdravil, salbutamola/ipratropijevega bromida, peroralnih agonistov β2 in zdravil s teofilinom v času zdravljenja ni bila dovoljena.
The Salmeterol Multi-center Asthma Research Trial (SMART) 
Multicentrično raziskovalno preskušanje zdravljenja astme s salmeterolom (SMART, The Salmeterol Multi-center Asthma Research Trial)
Situations, which could potentially trigger acute adrenal crisis include trauma, surgery, infection or any rapid reduction in dosage. 
Med okoliščinami, ki lahko sprožijo akutno adrenalno krizo, so poškodbe, kirurški posegi, okužbe in vsako hitro zmanjšanje odmerka.
The pharmacological effects of β2 agonist treatment, such as tremor, palpitations and headache, have been reported, but tend to be transient and reduce with regular therapy. 
Poročali so o farmakoloških učinkih zdravljenja z agonisti β2, kot so tremor, palpitacije in glavobol, ki so bili običajno prehodni in so se pri rednem zdravljenju ublažili.
Consideration should be given to increasing corticosteroid 
Razmisliti je treba o povečanju terapije s kortikosteroidom.
Place the mouthpiece between the teeth with the lips closed around the mouthpiece, do not bite the mouthpiece of the inhaler. 
Namestite ustnik med zobe in okoli njega stisnite ustnice, ne da bi v ustnik inhalatorja ugriznili.
• The dose indicator shows the number of inhalations remaining in even numbers only. 
• Kazalnik odmerka pokaže število inhalacij, ki je preostalo, samo za soda števila.
Your doctor has prescribed this medicine for the treatment of either • Severe asthma, to help prevent attacks of breathlessness and wheeziness, 
Zdravnik vam je to zdravilo predpisal za zdravljenje: • hude astme, da prepreči napade zasoplosti in piskajočega dihanja
Hence, clinically significant drug interactions mediated by fluticasone propionate 
Klinično pomembne interakcije zdravil zaradi flutikazonpropionata zato
Breathe: Breathe out gently (as far as is comfortable). 
Vdihnite: Nežno izdihnite (dokler to še ne predstavlja težave).
Co-administration with ketoconazole did not increase the elimination half-life of salmeterol or increase salmeterol accumulation with repeat dosing. 
Sočasno dajanje s ketokonazolom ni povečalo razpolovnega časa salmeterola ali povečalo kopičenja salmeterola ob ponavljajočih odmerkih.
Open: Hold the Spiromax with the mouthpiece cover at the bottom and open the mouthpiece cover by folding it down until it is fully opened when one click is heard. 
Odprite: Držite inhalator Spiromax pokonci, tako da je ustnik spodaj, in pokrovček ustnika odprite tako, da ga preganete navzdol, dokler ni povsem odprt in se zasliši klik.
The percentage of patients who died within 3 years due to COPD-related causes was 6.0% for placebo, 6.1% for salmeterol, 6.9% for FP and 4.7% for salmeterol/fluticasone propionate. 
Odstotek bolnikov, ki so v teku 3 let umrli zaradi razlogov, povezanih s KOPB, je bil 6,0 % za placebo, 6,1 % za salmeterol, 6,9 % za FP in 4,7 % za salmeterol/flutikazonpropionat.
Adverse reactions which have been associated with salmeterol/fluticasone propionate are given below, listed by system organ class and frequency. 
Neželeni učinki, povezani s salmeterolom/flutikazonpropionatom, so navedeni spodaj po organskem sistemu in pogostnosti.
The results of this study suggest that salmeterol/fluticasone propionate 50/100 micrograms twice daily may be considered as initial maintenance therapy in patients with moderate persistent asthma for whom rapid control of asthma is deemed essential (see section 4.2). 
Izsledki te študije kažejo, da se lahko salmeterol/flutikazonpropionat 50/100 mikrogramov dvakrat na dan uporablja kot uvodno vzdrževalno zdravljenje za bolnike z zmerno, perzistentno astmo, pri katerih je hitro obvladovanje astme ključno (glejte poglavje 4.2).
A similar incidence of pneumonia in the salmeterol/fluticasone propionate group was seen across all studies. 
Podobno incidenco pljučnice so v skupini, ki je prejemala salmeterol/flutikazonpropionat, opazili v vseh študijah.
The marketing authorisation holder shall submit the first periodic safety update report for this product within 
Imetnik dovoljenja za promet z zdravilom mora prvo redno posodobljeno poročilo o varnosti zdravila za to zdravilo predložiti v 6 mesecih po pridobitvi dovoljenja za promet.
Systemic effects may occur with any inhaled corticosteroid, particularly at high doses prescribed for long periods. 
Sistemski učinki se lahko pojavijo pri zdravljenju s katerim koli inhalacijskim kortikosteroidom, zlasti v primeru velikih odmerkov, predpisanih za daljše obdobje.
The signs and symptoms of salmeterol overdose are dizziness, increases in systolic blood pressure, tremor, headache and tachycardia. 
Znaki in simptomi prevelikega odmerjanja salmeterola so omotica, povečanje sistoličnega krvnega tlaka, tremor, glavobol in tahikardija.
You must use Aerivio Spiromax every day as directed by your doctor. 
Zdravilo Aerivio Spiromax morate uporabljati vsak dan, kot vam je predpisal zdravnik.
The studies described below (GOAL, TORCH and SMART) were carried out with this same fixed-dose combination, salmeterol xinafoate and fluticasone propionate, but studied a previously authorised product; the studies described were not carried out with Aerivio Spiromax. 
Študije, opisane v nadaljevanju (GOAL, TORCH in SMART), so bile izvedene z enako fiksno kombinacijo odmerkov salmeterolijevega ksinafoata in flutikazonpropionata, vendar s predhodno odobrenim zdravilom; opisane študije niso bile izvedene z zdravilom Aerivio Spiromax.
This medicine should not be used in children or adolescents under the age of 18 years. 
Tega zdravila se ne sme uporabljati pri otrocih in mladostnikih, mlajših od 18 let.
It is unknown whether salmeterol and fluticasone propionate /metabolites are excreted in human milk. 
Ni znano, ali se salmeterol in flutikazonpropionat/presnovki izločajo v materino mleko.
Packs of 1 and 3 inhalers. 
Velikosti pakiranja 1 inhalator ali 3 inhalatorji.
This may lead to an increase in the incidence of other systemic effects of salmeterol treatment (e.g. prolongation of QTc interval and palpitations) compared with salmeterol or ketoconazole treatment alone (see section 4.4). 
To lahko povzroči povečanje incidence drugih sistemskih učinkov zdravljenja s salmeterolom (npr. podaljšanje intervala QTc in palpitacije) v primerjavi z zdravljenjem s samo salmeterolom ali ketokonazolom (glejte
There was no increase in pneumonia related deaths; deaths while on treatment that were adjudicated as primarily due to pneumonia were 7 for placebo, 9 for salmeterol, 13 for FP and 8 for salmeterol/fluticasone propionate. 
Porasta smrti, povezanih s pljučnico, ni bilo; v času zdravljenja je bilo število smrti, ki so bile primarno pripisane pljučnici, 7 za placebo, 9 za salmeterol, 13 za FP in 8 za salmeterol/flutikazonpropionat.
• Aerivio Spiromax should be inhaled through the mouth into the lungs. 
• Zdravilo Aerivio Spiromax inhalirajte v pljuča skozi usta.
Severe asthma in adults 18 years of age and older 
Huda astma pri odraslih, starih 18 let in več
Particular caution is advised in acute severe asthma as this effect may be potentiated by concomitant treatment with xanthine derivatives, steroids and diuretics. 
Posebna pozornost se svetuje pri akutni hudi astmi, saj lahko sočasno zdravljenje z derivati ksantina, steroidi in diuretiki ta učinek še okrepi.
Each inhaler contains 60 doses and is foil-wrapped. 
En inhalator vsebuje 60 odmerkov in je zavit v folijo.
However, animal studies showed no effects of salmeterol or fluticasone 
Študije na živalih ne kažejo vpliva salmeterola ali flutikazonpropionata na
SMART was a multi-centre, randomised, double blind, placebo-controlled, parallel group 28-week study in the US which randomised 13,176 patients to salmeterol (50 micrograms twice daily) and 13,179 patients to placebo in addition to the patients' usual asthma therapy. 
SMART je bila 28-tedenska multicentična, randomizirana, dvojno slepa, s placebom nadzorovana študija s paralelnimi skupinami v ZDA, v kateri je bilo 13.176 bolnikov randomiziranih za salmeterol (50 mikrogramov dvakrat na dan) in 13.179 bolnikov za placebo, poleg običajnega zdravljenja, ki so ga bolniki uporabljali za astmo.
When the numbers become red in the window, you should see your doctor and get a 
Ko v okencu vidite rdeča števila, obiščite zdravnika, da si priskrbite nov inhalator.
If Aerivio Spiromax therapy has to be withdrawn due to overdose of the β agonist component of the medicinal product, provision of appropriate replacement steroid therapy should be considered. 
Če je treba zdravljenje z zdravilom Aerivio Spiromax prekiniti zaradi prevelikega odmerjanja agonista β v zdravilu, morate pretehtati ustrezno nadomestno terapijo s steroidom.
Clinically significant effects were not seen on blood pressure, heart rate, blood glucose and blood potassium levels. 
Klinično pomembnih učinkov na krvni tlak, srčni utrip, glukozo v krvi in raven kalija v krvi niso opazili.
Data from a large clinical trial (the Salmeterol Multi-Center Asthma Research Trial, SMART) suggested African-American patients were at increased risk of serious respiratory-related events or deaths when using salmeterol compared with placebo (see section 5.1). 
Podatki iz obsežnega kliničnega preskušanja (Multicentrično raziskovalno preskušanje zdravljenja astme s salmeterolom - SMART (Salmeterol Multi-Center Asthma Research Trial)) kažejo, da je pri bolnikih afroameriškega porekla tveganje hudih z dihali povezanih dogodkov ali celo smrti pri uporabi salmeterola v primerjavi s placebom večje (glejte poglavje 5.1).
The impact of optimal training (i.e. breathing in forcefully upon inhalation) in dry powder inhaler inhalation technique on inhalation speed and volume was assessed in these subject groups, together with assessment of potential differences in inhalation outputs according to the devices used. 
V skupini oseb je bil ocenjen vpliv optimalnega usposabljanja (tj. silovit vdih ob inhalaciji) pri inhalacijski tehniki z inhalatorjem s suhim praškom na hitrost in volumen, skupaj z oceno možnih izstopnih razlik pri inhalaciji glede na različne pripomočke.
These effects are much less likely to occur than with oral corticosteroids. 
Verjetnost, da se bodo ti učinki pojavili, je veliko manjša kot med uporabo peroralnih kortikosteroidov.
Tell your doctor if you notice any of the following symptoms while taking Aerivio Spiromax as they could be symptoms of a lung infection: fever or chills; increased mucus production, changes in mucus colour; increased cough or increased breathing difficulties. 
Zdravniku povejte, če med uporabo zdravila Aerivio Spiromax opazite kar koli od naslednjega, saj so lahko to simptomi okužbe pljuč: zvišano telesno temperaturo ali mrzlico; obilnejše nastajanje sluzi, spremenjeno barvo sluzi; močnejši
During the study, patients were permitted usual COPD therapy with the exception of other inhaled corticosteroids, long-acting bronchodilators and long-term systemic corticosteroids. 
V času študije je bilo bolnikom dovoljeno uporabljati običajna zdravila za zdravljenje KOPB, z izjemo drugih inhalacijskih kortikosteroidov, dolgodelujočih bronhodilatatorjev in sistemskih kortikosteroidov za kronično uporabo.
Patients with severe lactose intolerance should use this medicine with caution and those with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. 
Bolniki s hudo intoleranco za laktozo morajo to zdravilo uporabljati previdno, bolniki z redko dedno intoleranco za galaktozo, laponsko obliko zmanjšane aktivnosti laktaze ali malabsorpcijo glukoze/galaktoze pa ne smejo jemati tega zdravila.
The dose should be titrated to the lowest dose at which effective control of symptoms is maintained. 
Odmerek je treba postopno titrirati do najmanjšega odmerka, ki še zagotavlja učinkovit nadzor simptomov bolezni.
The extent of the adrenal impairment may require specialist advice before elective procedures. 
Zaradi izrazitosti adrenalne prizadetosti utegne biti pred elektivnimi postopki potreben
A moderate amount of data on pregnant women (between 300 to 1000 pregnancy outcomes) indicates no malformative or feto/neonatal toxicity of salmeterol and fluticasone propionate. 
Manjše število podatkov o uporabi salmeterola in flutikazonpropionata pri nosečnicah (med 300 in 1.000 izpostavljenih nosečnosti) ne kaže na njuno malformacijsko ali feto/neonatalno toksičnost.
You may also have dizziness, a headache, muscle weakness and aching joints. 
Morda boste imeli tudi omotico, glavobol, šibkost mišic in boleče sklepe.
The drug/mucosal contact parts of the inhaler are made of acrylonitrile butadiene styrene (ABS), polyethylene (PE) , and polypropylene (PP). 
Deli inhalatorja, ki so v stiku z zdravilom/sluznico, so iz akrilonitril butadien stirena (ABS), polietilena (PE) in polipropilena (PP).
• Xanthine medicines such as aminophylline and theophylline. 
• Ksantinska zdravila, kot sta aminofilin in teofilin.
Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist with a long side chain which binds to 
Salmeterol je selektiven, dolgodelujoč (12 ur) agonist adrenergičnih receptorjev β2; ima dolgo stransko verigo, ki se veže na ekso-mesto receptorja.
Side panel: For use in adults 18 years of age and older only. 
Stranski del: Samo za uporabo pri odraslih, starih 18 let in več.
Information about this interaction is lacking for inhaled fluticasone propionate, but a marked increase in fluticasone propionate plasma levels is expected. 
Za inhalirani flutikazonpropionat informacij o tem medsebojnem delovanju ni, a pričakovati je mogoče izrazito povečanje koncentracije flutikazonpropionata v plazmi.